Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025512-002
Application #
2302284
Study Section
Project Start
1992-09-30
Project End
2008-09-29
Budget Start
1993-04-14
Budget End
1993-09-29
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Henry Ford Health System
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073134603
City
Detroit
State
MI
Country
United States
Zip Code
48202
Kang, Xiaozheng; Liu, Hongliang; Onaitis, Mark W et al. (2016) Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14,463 cases and 44,188 controls. Carcinogenesis 37:280-289
Pretzel, Shannon M; Andrews, Tara S; Broski, Karen et al. (2015) Participants' Views of Retention Materials Used in the PLCO Cancer Screening Trial. Clin Med Res 13:139-48
Cote, Michele L; Alhajj, Tala; Ruterbusch, Julie J et al. (2015) Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes Control 26:287-296
Alford, Sharon Hensley; Rattan, Ramandeep; Buekers, Thomas E et al. (2015) Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Cancer 121:441-7
Brenner, Darren R; Amos, Christopher I; Brhane, Yonathan et al. (2015) Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis 36:1314-26
Tammemägi, Martin C; Berg, Christine D; Riley, Thomas L et al. (2014) Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst 106:dju084
Pinsky, Paul F; Gierada, David S; Hocking, William et al. (2014) National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med 161:627-33
Kvale, Paul A; Johnson, Christine Cole; Tammemägi, Martin et al. (2014) Interval lung cancers not detected on screening chest X-rays: How are they different? Lung Cancer 86:41-6
Wang, Yufei; McKay, James D; Rafnar, Thorunn et al. (2014) Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet 46:736-41
Gierada, David S; Pinsky, Paul; Nath, Hrudaya et al. (2014) Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst 106:

Showing the most recent 10 out of 50 publications